Quick Comparison

Azelaic AcidTretinoin
Typical ConcentrationOTC: 10% (The Ordinary). Prescription: 15% gel (Finacea for rosacea), 20% cream (Azelex for acne). Apply twice daily. Well-tolerated but may sting/itch initially. Full effects at 8-12 weeks.Concentrations: 0.025%, 0.05%, 0.1%. Start with 0.025% every other night for 4-6 weeks, then increase frequency. Apply pea-sized amount to dry face 20 minutes after cleansing. Always use with SPF 30+ during the day. Retinization period: 4-12 weeks of initial irritation.
ApplicationTopical (gel, cream, serum). Slightly gritty texture in some formulations. Apply to clean skin.Topical (cream, gel, microsphere). Apply to clean, dry skin at night. Microsphere formulations (Retin-A Micro) release tretinoin slowly, reducing irritation.
Research Papers9 papers10 papers
Categories

Mechanism of Action

Azelaic Acid

Azelaic acid exhibits multi-modal activity: (1) Tyrosinase inhibition—competitively inhibits tyrosinase selectively in hyperactive melanocytes (melasma, PIH) while sparing normal ones; may involve mitochondrial enzyme interference in dysregulated melanocytes. (2) Antimicrobial—bacteriostatic against Cutibacterium acnes by inhibiting bacterial protein synthesis. (3) Comedolytic—normalizes follicular keratinization, reducing hyperkeratinization and corneocyte cohesion; may modulate keratinocyte differentiation. (4) Anti-inflammatory—scavenges ROS, inhibits neutrophil free radicals, reduces pro-inflammatory cytokines. Inhibits 5-alpha-reductase in sebocytes, potentially reducing sebum. Multi-pathway activity explains efficacy in acne, rosacea, and hyperpigmentation. Safe during pregnancy.

Tretinoin

Tretinoin binds nuclear retinoic acid receptors (RAR-alpha, beta, gamma), forming RAR/RXR heterodimers that bind retinoic acid response elements and activate gene transcription. This accelerates keratinocyte proliferation, reducing stratum corneum transit from ~28 to ~14 days. In the dermis, tretinoin stimulates fibroblasts and upregulates collagen I and III via TGF-beta while downregulating MMP-1, MMP-3, and MMP-9 that degrade the extracellular matrix. It normalizes melanocyte distribution and melanosome transfer. In acne, it prevents microcomedo formation by normalizing follicular keratinocyte differentiation and reducing corneocyte cohesion. RAR activation also modulates genes for epidermal growth factors and differentiation markers.

Risks & Safety

Azelaic Acid

Common

Stinging, burning, itching on initial application (usually subsides within 2 weeks). Mild dryness.

Serious

None. Safe during pregnancy and breastfeeding.

Rare

Allergic contact dermatitis, hypopigmentation (rare at cosmetic concentrations).

Tretinoin

Common

Dryness, peeling, redness, increased sun sensitivity (mandatory SPF). Initial purging (breakouts) for 4-8 weeks.

Serious

Teratogenic — absolutely contraindicated in pregnancy and breastfeeding.

Rare

Severe irritant contact dermatitis, eczema flare-ups.

Full Profiles